A Survey on the Under-treatment of hypercholeSterolemia (EPHESUS Trial)

Conditions

Hyperlipidemias

Brief summary

In this study, within the secondary prevention group patients ( diabetes mellitus, coronary artery disease, peripheral artery disease, who have had events atherosclerotic cerebrovascular ) , statin use requirement , patients compliance and reaching target LDL-cholesterol levels (according to European guidelines ) will be evaluated.

Detailed description

In the majority of patients treated with lipid lowering agents are not under control in accordance with the lipids manual. In this study, within the secondary prevention group patients ( diabetes mellitus, coronary artery disease, peripheral artery disease, who have had events atherosclerotic cerebrovascular ) , statin use requirement , patients compliance and reaching target LDL-cholesterol levels (according to European guidelines ) will be evaluated. The investigators' aim is to determine the role of education and knowledge in reaching target LDL cholesterol levels in these patients. İn addition , the investigators want to emphasize in high-risk patients who are receiving or not receiving cholesterol-lowering treatment what is their target values , (LDL \< 100 mg / dL and high -risk patients with LDL \< 70 mg / dL in very high-risk patients ) and to determine what is the rate of patients and to the importance of reaching their target cholesterol levels. İn addition ,to evaluate the patients habits of the using statin dose .After screening , physician treatment decisions and reasons will be documented.

Doğan V, Başaran Ö, Özlek B, Çelik O, Özlek E, Çil C, Özdemir IH, Rencüzoğulları I, Özpamuk Karadeniz F, Bekar L, Aktas M, Resulzade MM, Kalçık M, Aksan G, Çinier G, Halli Akay K, Mert KU, Biteker M, Kayıkçıoğlu M.

2019-10-0110 citations

10.5543/tkda.2019.39293

The reasons of poor lipid target attainment for secondary prevention in real life practice: Results from EPHESUS.

Mert GÖ, Başaran Ö, Mert KU, Doğan V, Özlek B, Çelik O, Özlek E, Çil C, Özdemir İH, Rencüzoğulları İ, Karadeniz FÖ, Bekar L, Aktaş M, Resulzade MM, Kalçık M, Aksan G, Çinier G, Akay K, Pekel N, Şenol U, Biteker M, Kayıkçıoğlu M.

2019-05-2215 citations

10.1111/ijcp.13358

Rationale, design, and methodology of the Evaluation of Perceptions, Knowledge, and Compliance with the Guidelines in Real Life Practice: A Survey on the Under-treatment of Hypercholesterolemia.

Doğan V, Başaran Ö, Özlek B, Çelik O, Özlek E, Mert KU, Rencüzoğulları İ, Mert GÖ, Doğan MM, Biteker M, Kayıkçıoğlu M.

2018-01-015 citations

10.5543/tkda.2017.73861

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

No

Inclusion criteria

* Patients with coronary artery disease (acute coronary syndromes, post- myocardial infarction patients, who have a history of percutaneous coronary intervention , history of coronary artery by-pass graft ) * Patients with carotid artery lesions or peripheral artery disease , * Type 2 diabetes mellitus patients

Exclusion criteria

* acute coronary syndrome in last 1 month * pregnancy or the first 6 months postpartum * ICU patients or emergency patients...etc.(other than polyclinic)

Design outcomes

Primary

Measure	Time frame
The number of patients with secondary prevention group receiving appropriate lipid lowering therapy	2 months

Outcome results